GenusPlus Group Statistics
Total Valuation
GenusPlus Group has a market cap or net worth of AUD 1.72 billion. The enterprise value is 1.42 billion.
| Market Cap | 1.72B |
| Enterprise Value | 1.42B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | Sep 30, 2026 |
Share Statistics
GenusPlus Group has 203.32 million shares outstanding. The number of shares has increased by 2.71% in one year.
| Current Share Class | 203.32M |
| Shares Outstanding | 203.32M |
| Shares Change (YoY) | +2.71% |
| Shares Change (QoQ) | +4.76% |
| Owned by Insiders (%) | 49.65% |
| Owned by Institutions (%) | 4.14% |
| Float | 99.57M |
Valuation Ratios
The trailing PE ratio is 32.29 and the forward PE ratio is 17.84.
| PE Ratio | 32.29 |
| Forward PE | 17.84 |
| PS Ratio | 1.34 |
| PB Ratio | 4.31 |
| P/TBV Ratio | 5.99 |
| P/FCF Ratio | 9.94 |
| P/OCF Ratio | 8.85 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.03, with an EV/FCF ratio of 8.24.
| EV / Earnings | 29.00 |
| EV / Sales | 1.11 |
| EV / EBITDA | 15.03 |
| EV / EBIT | 19.43 |
| EV / FCF | 8.24 |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.54 |
| Quick Ratio | 1.29 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.02 |
| Debt / FCF | 0.56 |
| Interest Coverage | 14.61 |
Financial Efficiency
Return on equity (ROE) is 17.59% and return on invested capital (ROIC) is 47.63%.
| Return on Equity (ROE) | 17.59% |
| Return on Assets (ROA) | 6.47% |
| Return on Invested Capital (ROIC) | 47.63% |
| Return on Capital Employed (ROCE) | 15.01% |
| Weighted Average Cost of Capital (WACC) | 7.47% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.81 |
| Inventory Turnover | 129.21 |
Taxes
In the past 12 months, GenusPlus Group has paid 23.60 million in taxes.
| Income Tax | 23.60M |
| Effective Tax Rate | 32.50% |
Stock Price Statistics
The stock price has increased by +63.90% in the last 52 weeks. The beta is 0.63, so GenusPlus Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.63 |
| 52-Week Price Change | +63.90% |
| 50-Day Moving Average | 9.14 |
| 200-Day Moving Average | 8.24 |
| Relative Strength Index (RSI) | 42.27 |
| Average Volume (20 Days) | 775,776 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GenusPlus Group had revenue of AUD 1.28 billion and earned 49.02 million in profits. Earnings per share was 0.26.
| Revenue | 1.28B |
| Gross Profit | 926.46M |
| Operating Income | 73.18M |
| Pretax Income | 72.63M |
| Net Income | 49.02M |
| EBITDA | 83.12M |
| EBIT | 73.18M |
| Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 390.60 million in cash and 96.20 million in debt, with a net cash position of 294.40 million or 1.45 per share.
| Cash & Cash Equivalents | 390.60M |
| Total Debt | 96.20M |
| Net Cash | 294.40M |
| Net Cash Per Share | 1.45 |
| Equity (Book Value) | 398.11M |
| Book Value Per Share | 1.96 |
| Working Capital | 243.83M |
Cash Flow
In the last 12 months, operating cash flow was 193.99 million and capital expenditures -21.41 million, giving a free cash flow of 172.58 million.
| Operating Cash Flow | 193.99M |
| Capital Expenditures | -21.41M |
| Depreciation & Amortization | 9.93M |
| Net Borrowing | -2.20M |
| Free Cash Flow | 172.58M |
| FCF Per Share | 0.85 |
Margins
Gross margin is 72.32%, with operating and profit margins of 5.71% and 3.83%.
| Gross Margin | 72.32% |
| Operating Margin | 5.71% |
| Pretax Margin | 5.67% |
| Profit Margin | 3.83% |
| EBITDA Margin | 6.49% |
| EBIT Margin | 5.71% |
| FCF Margin | 13.47% |
Dividends & Yields
This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.87%.
| Dividend Per Share | 0.07 |
| Dividend Yield | 0.87% |
| Dividend Growth (YoY) | 55.56% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 20.70% |
| Buyback Yield | -2.71% |
| Shareholder Yield | -1.84% |
| Earnings Yield | 2.86% |
| FCF Yield | 10.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for GenusPlus Group is 12.14, which is 44.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 12.14 |
| Price Target Difference | 44.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 21.57% |
| EPS Growth Forecast (3Y) | 26.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GenusPlus Group has an Altman Z-Score of 3.55 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.55 |
| Piotroski F-Score | 5 |